Capital Performance Advisors LLP Charles River Laboratories International, Inc. Transaction History
Capital Performance Advisors LLP
- $325 Million
- Q3 2024
A detailed history of Capital Performance Advisors LLP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Capital Performance Advisors LLP holds 6 shares of CRL stock, worth $1,085. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6Holding current value
$1,085% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
720Shares Held
51.9MCall Options Held
233KPut Options Held
236K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.1 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$921 Million0.02% of portfolio
-
State Street Corp Boston, MA2.09MShares$378 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.91MShares$345 Million0.99% of portfolio
-
Allspring Global Investments Holdings, LLC1.76MShares$319 Million0.56% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.2B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...